Synergy Research   Report issue

For profit Phase 2 Phase 3
Founded: Lemon Grove CA United States (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2008
NCT00734435
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Synergy Clinical Research | Synergy Clinical Research Center | Synergy Escondido | Synergy Research Group | Synergy Research Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcoholism (Phase 3)

Compulsive Personality Disorder (Phase 2)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Treatment-Resistant (Phase 2)

Disease (Phase 2)

Hepatitis (Phase 3)

Hepatitis C (Phase 3)

Hepatitis C, Chronic (Phase 3)

Liver Cirrhosis (Phase 3)

Metabolic Syndrome (Phase 3)

Obsessive-Compulsive Disorder (Phase 2)

Psychotic Disorders (Phase 2)

Schizophrenia (Phase 2)

Syndrome (Phase 3)

Urinary Bladder, Overactive (Phase 3)

Weight Gain (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 14